Revenue segments as reported by the company.

Smokeable Products

Oral Tobacco Products

Wine

All Other

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Marketing, administration and research costs

Asset impairment and exit costs

Amortization of intangibles

General corporate expenses

Corporate asset impairment and exit costs

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Altria

Altria Group, Inc. operates as a holding company, which engages in the manufacture and sale of cigarettes in the United States. It operates through the following segments: Smokeable Products, Oral tobacco products, and Wine. The Smokeable Products segment consists of cigarettes manufactured and sold by PM USA and machine-made large cigars and pipe tobacco manufactured and sold by Middleton. The Oral tobacco products segment is primarily moist smokeless tobacco products (MSTs) through brands like Copenhagen and Skoal as well as on! oral nicotine pouches sold by Helix. The Wine segment, through subsidiary Ste. Michelle Wine Estates Ltd, produces Washington State wines, primarily Chateau Ste. Michelle and 14 Hands, and owns wineries in or distributes wines from several other wine regions. The company was founded in 1919 and is headquartered in Richmond, VA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Altria reports robust Q4 earnings, focuses on innovation and growth

Altria's Q4 2022 performance reflects resilience amidst industry challenges, with a focus on innovation and shareholder returns. The company's strategic initiatives in smoke-free products and digital engagement underscore its commitment to long-term growth and harm reduction.

Altria reports resilient Q1 performance amid industry challenges and opportunities

Altria's Q1 2023 earnings call highlighted strong performance amidst industry challenges, emphasizing harm reduction and regulatory compliance. The company faces hurdles from inflation, regulatory changes, and evolving consumer behaviors, while focusing on growth opportunities in smoke-free products and strategic investments.

Altria reports solid Q2 earnings, eyes e-vapor growth opportunities

Altria's focus on smoke-free products and NJOY acquisition driving growth.
Challenges in the cigarette industry due to economic pressures and flavor bans.
Opportunities in the e-vapor category and expansion plans in the U.S.
Strong balance sheet and significant capital returns to shareholders.

Altria reports growth in earnings, navigates regulatory challenges in e-vapor

Altria's Q3 2023 earnings call highlighted solid financial performance, strategic focus on e-vapor products, and efforts to combat illegal vape products. The company faces challenges from regulatory uncertainties and illicit products but sees opportunities in expanding NJOY's reach and addressing market gaps.

Altria reports growth in smoke-free products amidst regulatory challenges

Altria's Q4 2023 earnings call highlighted growth in adjusted EPS, strategic focus on smoke-free products, and efforts to combat illicit e-vapor products. The company faces challenges in competitive segments and economic pressures but sees opportunities in new product introductions and regulatory collaborations.

Altria reports mixed Q1 performance, focuses on growth strategies

Altria's Q1 performance showed growth in NJOY and oral tobacco segments, with challenges in EPS decline and economic pressures on consumers.
Strengths include reaffirmed EPS guidance, strategic investments, and focus on combating illicit e-vapor products.
Opportunities lie in maximizing profitability in oral tobacco, product positioning, and capturing transitioning consumers.
Overall, Altria's performance reflects a mix of growth, challenges, and strategic opportunities in navigating market dynamics.

Altria's NJOY drives growth as company navigates e-vapor challenges

Altria's Q2 2024 earnings call showcased strong performance in smoke-free products, highlighting growth in retail share and volume momentum. Despite challenges in the e-vapor category, the company remains focused on responsible regulation and enforcement. With a commitment to shareholder value and long-term growth strategies, Altria is poised for continued success.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Altria Group, Inc. is a holding company, which engages in the manufacture and sale of cigarettes in the United States. It operates through the following segments: Smokeable Products, Oral Tobacco Products, and All Other. The Smokeable Products segment consists of cigarettes manufactured and sold by PM USA, and machine-made large cigars and pipe tobacco manufactured and sold by Middleton. The Oral Tobacco Products segment includes MST and snus products manufactured and sold by USSTC, and oral nicotine pouches manufactured and sold by Helix. The All Other segment refers to the financial results of NJOY, Helix ROW, and the IQOS System heated tobacco business. The company was founded in 1919 and is headquartered in Richmond, VA.

Energy Transfer LP Unit

KeyCorp

Omega Healthcare Investors

OneMain Hld

Pioneer Natural Resources

Verizon

Wall Street is giddy again after the S&P 500 burst out of the longest bear market in over 70 years in June and then tacked on another 15% in July.

Sell Any August Rallies and Move to 7 ‘Strong Buy' Analyst Favorites With Huge Dividends

Altria Group reaffirms guidance for 2023 fiscal year and remains a profitable powerhouse in the tobacco industry. MO demonstrates strong profitability and cash flow, with an increase in net earnings and free cash flow. The acquisition of NJOY Holdings expands MO's diversification and solidifies its position in the marketplace, positioning it for a non-combustible future.

Altria Group Looks Undervalued With A Dividend Exceeding 8%

AbbVie

ABM Industries

Black Hills

Colgate-Palmolive

Emerson Electric

Federal Realty Investment Trust

Genuine Parts

Gorman-Rupp

Leggett & Platt

National Fuel Gas

Northwest Natural Gas

SJW Group

Sysco

Target

Universal Corp

"There is only one-criterion to be included among the Dividend Kings: a publicly-traded company must increase its total fiscal-year dividend-payout for a minimum of 50 consecutive-years."--Dogs of the Dow. The 50 Dividend Kings screened as of July 28, 2023, represented nine of eleven Morningstar Sectors. Broker targeted-top-ten net-gainers ranged 13.68%-34.52% topped-by Target, and Gorman-Rupp. By yield, Altria tops-all. Top-ten Kingly August yields from NFG, ABBV, BKH, FRT, NWN, MMM, CDUAF, LEG, UVV, & MO averaged 5.24%.

Buy 5 August Dividend Kings, Watch 4 More

Altria Group shares are slightly lower Tuesday after the firm posted second-quarter results roughly in line with analyst expectations.  The tobacco company reported adjusted revenue of  $5.44 billion, up 1% year-over-year but just short of Zacks' consensus projection of $5.45 billion.

Altria Group shares slide after 2Q results fail to beat expectations

The headline numbers for Altria (MO) give insight into how the company performed in the quarter ended June 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Compared to Estimates, Altria (MO) Q2 Earnings: A Look at Key Metrics

Altria's (MO) second-quarter 2023 results benefit from increased pricing, whereas lower shipment volumes remain a downside.

Altria's (MO) Q2 Earnings Meet Estimates, Revenues Down Y/Y

Altria (MO) came out with quarterly earnings of $1.31 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $1.26 per share a year ago.

Altria (MO) Matches Q2 Earnings Estimates

The maker of Malboro cigarettes saw revenue hit by lower cigarette volumes. Price hikes helped offset that.

Altria Posts Narrow Earnings Beat and Maintains Profit Forecast

Altria Group Inc. MO, -0.15% stock was down fractionally in premarket trading on Tuesday after the tobacco company's profit more than doubled. The company said its second-quarter net income rose to $2.117 billion, or $1.19 a share, from $891 million, or 49 cents a share, in the year-ago quarter.

Altria's second-quarter adjusted profit more than doubles

RICHMOND, Va.--(BUSINESS WIRE)---- $MO #ALTRIA--Altria Reports 2023 Second-Quarter and First-Half Results; Reaffirms 2023 Full-Year Earnings Guidance.

Altria Reports 2023 Second-Quarter and First-Half Results; Reaffirms 2023 Full-Year Earnings Guidance

E-cigarette company Juul Labs is seeking US authorization to sell a "next-generation" vape with age verification capabilities in the United States.

Juul seeks authorization on a new vape it says can verify a user's age. Here's how it works

Coterra Energy

Devon Energy

Lincoln National

PG&E

AT&T

Truist Financial

V.F.

It's possible to score 5% yields on CDs. So to even consider dividend paying S&P 500 stocks the yield had better be impressive.

Only 11 Stocks' Dividends Are Impressive Now That CDs Yield 5.4%

Johnson & Johnson

Income stocks have meaningfully outperformed publicly traded companies that don't pay a dividend over extended timelines. Dividend Kings -- companies that have raised their base annual payout for at least 50 consecutive years -- are in a class of their own.

Want $500 in Super Safe Annual Dividend Income? Invest $9,900 in the Following 3 Dividend Kings

Citigroup

Chevron

Kraft Heinz

Pfizer

For investors, 2022 was a dreadful year. The S&P 500 was down almost 20% and the Nasdaq lower by a stunning 33%.

Top JP Morgan Strategist Says the Worst May Still Be Coming: 7 Big-Dividend Blue Chips to Buy Now

Enbridge

Coca-Cola

Altria's pricing power allowed it to maintain revenue growth even as cigarette usage declined. Enbridge has a $12.8 billion backlog of future projects.

The Best Dividend Stocks to Invest $1,000 in Right Now

The tobacco company is struggling to divest away from the declining industry.

Is Altria Group's 8.2% Dividend Yield Safe for the Long Run?

Altria is one of the largest cigarette makers in the United States. There is a societal shift away from cigarettes.

Where Will Altria Be in 5 Years?

Algonquin Power & Utilities

VAALCO Energy

Kohl's

Bank of N.T. Butterfield & Son

Sachem Capital

Sinclair Inc

When it comes to selecting the best dividend stocks, an approach worth exploring is focusing on undervalued high-yield stocks. It's easy to conflate a high dividend yield with a low valuation, but this is often not true.

The 7 Most Undervalued High-Yield Stocks to Buy Now July 2023

The e-cigarette is seeking FDA authorization on a next-gen product that won't work with unauthorized cartridges. After being buried in lawsuits in recent years accusing it of contributing to underage vaping and tobacco use, it may have been safe to assume that Juul Labs' future went up in smoke.

Is Juul making a comeback? Embattled vape company readies new device with age-verification tech

Ethical concerns may drive the investment decision in Altria. Non-income investors may want to avoid the stock.

3 Things About Altria Stock That Smart Investors Know

Kinder Morgan

Realty Income Corp

SL Green Realty

The Dividend Harvesting Portfolio has seen its best week since week 101, closing week 124 with a balance of $12,837.19, a 3.53% profit on invested capital. The portfolio's primary focus is generating a continuous stream of income, with a secondary focus on downside mitigation and a third priority of capital appreciation. The portfolio is projected to generate $1,062.78 in annual dividend income, breaking down to $88.56 per month, $20.44 per week, and $2.91 per day.

Dividend Harvesting Portfolio Week 124: $12,400 Allocated, $1,062.78 In Projected Dividends

Altria's stake in Anheuser-Busch InBev is worth more than $11 billion. Selling the stake could unlock capital to dramatically reduce the dividend payout ratio and fuel earnings growth. MO stock is a solid candidate for 13% annual returns and more if it sells its stake.

It's Time That Altria Unleashes Its $11 Billion Ace In The Hole

British American Tobacco

The two tobacco companies offer investors excellent dividend yields.

Best High-Yield Dividend Stock to Buy: Altria vs. British American Tobacco

Altria Group is set to report Q2 results on August 1, with analysts expecting an EPS of $1.30 on revenue of $5.44 billion, representing an EPS growth of 3.34% and revenue growth of 1.30% YoY. The company has consistently beaten EPS estimates but has struggled with revenue estimates, with declines in shipment volume being a significant concern. Despite challenges, the stock is undervalued and the company's upcoming dividend increase and diversification efforts, including its NJOY acquisition, are positives.

Altria Q2 Earnings Preview: Watch The Volume Decline

Over the last several years, Juul has gone from a darling of Silicon Valley to a company beset by legal challenges. The e-cigarette maker recently agreed to pay $462 million in a settlement that ends lawsuits against it.

The rise and fall of Juul: The e-cigarette maker's comeback plan includes a high-tech vape and a 'shots-on-goal' approach to the FDA

News for Altria Stock (MO)